IRWD · CIK 0001446847 · FY2025 live · 2025-12-31
IRONWOOD PHARMACEUTICALS INC
View as
Model
Classic Z
FY2025
−4.48
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−4.48
Z″ −11.97
Score −4.48 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.081.2 × = 0.10X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−4.221.4 × = −5.90X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
0.253.3 × = 0.82X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
−0.400.6 × = −0.24X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.751 × = 0.75
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
IRONWOOD PHARMACEUTICALS INC is on classic Z at −4.48 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 32nd percentile in Healthcare.
- RAREDistressUltragenyx Pharmaceutical Inc.−4.44
- AQSTDistressAquestive Therapeutics, Inc.−4.43
- RLMDDistressRELMADA THERAPEUTICS, INC.−4.43
- INBXDistressInhibrx Biosciences, Inc.−4.54
- ANNXDistressAnnexon, Inc.−4.41
- TILDistressInstil Bio, Inc.−4.41
- MENSDistressJyong Biotech Ltd.−4.40
- QCLSDistressQ/C TECHNOLOGIES, INC.−4.57
KPI widgets
Current assets
$274M
Total assets
$397M
Current liabilities
$242M
Total liabilities
$659M
Working capital
$32M
Retained earnings
−$1.7B
EBIT
$99M
Total sales
$296M
Book equity
−$262M
Accession 0001104659-26-020489. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.